The mitogenic activity of hepatocyte growth factor on rat hepatocytes is dependent upon endogenous transforming growth factor-α

American Journal of Pathology

Volumn 157, Issue 5, 2000, Pages 1693-1701

  Tomiya, Tomoaki ^a   Ogata, Itsuro ^a   Yamaoka, Miho ^b   Yanase, Mikio ^a   Inoue, Yukiko ^a   Fujiwara, Kenji ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA DETERMINATION; DNA SYNTHESIS; LIVER CELL CULTURE; MALE; MITOGENESIS; NONHUMAN; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; RAT;

EID: 0033710782     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64806-7     Document Type: Article

References (78)

1. Hepatic regeneration
2. Liver regeneration: Molecular mechanisms of growth control
3. TGFα overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas
4. Hepatocyte growth factor in transgenic mice: Effects on hepatocyte growth, liver regeneration and gene expression
5. Direct evidence that hepatocyte growth factor is a hepatotropic factor for liver regeneration and has a potent antihepatitis effect in vivo
6. Stimulation of liver growth by exogenous human hepatocyte growth factor in normal and partially hepatectomized rats
7. In vivo response of hepatocytes to growth factors requires an initial priming stimulus
8. Collagenase pretreatment and mitogenic effects of hepatocyte growth factor and transforming growth factor-α in adult rat liver
9. Transforming growth factors produced by certain human tumor cells: Polypeptides that interact with epidermal growth factor receptors
10. Epidermal growth factor-like transforming growth factor. II. Interaction with epidermal growth factor receptors on human placenta membrane and A431 cells
11. Transforming growth α
12. Expression of epidermal growth factor receptor proto-oncogene mRNA in regenerating rat liver
13. Transforming growth factor α may be a physiological regulator of liver regeneration by means of an autocrine mechanism
14. Metabolism and effects of epidermal growth factor and related growth factors in mammals
15. Marked increase of HGF mRNA in non-parenchymal liver cells of rats treated with hepatotoxins
16. Expression of hepatocyte growth factor gene in endothelial and Kupffer cells of damaged rat livers, as revealed by in situ hybridization
17. Identification and partial characterization of receptor binding sites for HGF on rat hepatocytes
18. Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the protooncogene c-MET
19. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product
20. Identification and change in the receptor for hepatocyte growth factor in rat liver after partial hepatectomy or induced hepatitis
21. Hepatocyte growth factor/hepatopoietin A is expressed in fat-storing cells from rat liver but not myofibroblast-like cells derived from fatstoring cells
22. Expression of hepatocyte growth factor and c-met genes during hepatic differentiation and liver development in the rat
23. Transforming growth factor α levels in liver and blood correlate better than hepatocyte growth factor with hepatocyte proliferation during liver regeneration
24. Transforming growth factor-α expression during liver regeneration after partial hepatectomy and toxic injury, and potential interactions between transforming growth factor-α and hepatocyte growth factor
25. Possible endocrine control of liver regeneration after partial hepatectomy
26. Expression of hepatocyte growth factor mRNA in regenerating rat liver after partial hepatectomy
27. Serum levels of transforming growth factor-α in patients after partial hepatectomy as determined with an enzyme-linked immunosorbent assay
28. Serum hepatocyte growth factor levels in hepatectomized and nonhepatectomized surgical patients
29. Serum transforming growth factor level can be a parameter for evaluating liver regeneration after partial hepatectomy in patients with liver cancer
30. Liver regeneration in fulminant hepatitis as evaluated by serum transforming growth factor α levels
31. Significance of serum human hepatocyte growth factor levels in patients with hepatic failure
32. Tumor cytotoxic factor/hepatocyte growth factor from human fibroblasts: Cloning of its cDNA, purification and characterization of recombinant protein
33. Rapid and sensitive enzyme-linked immunosorbent assay for measurement of HGF in rat and human tissues
34. Specific regulation by antisense, sense and antigene nucleic acids
35. Inhibition of human immunodeficiency virus replication by antisense oligonucleotides
36. Cloning and sequence analysis of a cDNA for rat transforming growth factor-α
37. A new sandwich enzyme-linked immunosorbent assay (ELISA) for transforming growth factor α (TGFα) based upon conformational modification by antibody binding
38. Detection of transforming growth factor alpha in human urine and plasma
39. A rapid and sensitive method for the quantitation of microgram quantifies of protein utilizing principle of protein-dye binding
40. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
41. Preparation of isolated rat liver cells
42. Cells en route to apoptosis are characterized by the upregulation of c-fos, c-myc, c-jun, cdc2, and RB phosphorylation, resembling events of early cell-cycle traverse
43. Phenobarbital modulates the type of cell death by rat hepatocytes during deprivation of serum in vitro
44. The proto-oncogene c-myc and apoptosis
45. Increased survival of rat hepatocytes in serum-free medium by inhibition of a trypsin-like protease associated with their plasma membranes
46. Identification of trypsin inhibitor in bovine pituitary extracts as a survival factor for adult rat hepatocytes in primary culture
47. Hepatocyte growth factor for liver disease
48. Protective action of hepatocyte growth factor for acute liver injury caused by D-galactosamine in transgenic mice
49. Hepatocyte growth factor promotes liver regeneration with prompt improvement of hyperbilirubinemia in hepatectomized cholestatic rats
50. Hepatocyte growth factor prevents endotoxin-induced lethal hepatic failure in mice
51. Hepatocyte growth factor and its variant with a deletion of five amino acids are distinguishable in their biological activity and tertiary structure
52. Inhibition of tumor growth in liver epithelial cells transfected with a transforming growth factor alpha antisense gene
53. A diversity of EGF-like ligands and receptors in liver
54. Liver expression of epidermal growth factor RNA. Rapid increase in immediate-early phase of liver regeneration
55. Effects of epidermal growth factor and transforming growth factor alpha on the mouse trophoblast outgrowth in vitro
56. An enhanced and sensitive autocrine stimulation by transforming growth factor-α is acquired in the brain metastatic variant of a human non-small-cell lung cancer cell line
57. Interferon γ induces prostaglandin G/H synthase-2 through an autocrine loop via the epidermal growth factor receptor in human bronchial epithelial cells
58. Induction of apoptosis in a human hepatocellular carcinoma cell line by a neutralizing antibody to transforming growth factor-α
59. Inhibition of apolipoprotein B secretion by IL-6 is mediated by EGF or an EGF-like molecule in CaCo-2 cells
60. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice
61. Initiation of liver growth by tumor necrosis factor: Deficient liver regeneration in mice lacking type I tumor necrosis factor receptor
62. Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor: Requirement for type 1 but not type 2 receptor
63. Deficient liver regeneration after carbon tetrachloride injury in mice lacking type I but not type 2 tumor necrosis factor receptor
64. Coexpression of IL-6 and soluble IL-6R causes nodular regenerative hyperplasia and adenomas of the liver
65. Tumor necrosis factor primes hepatocytes for DNA replication in the rat
66. Transcriptional regulatory signals define cytokine-dependent and -independent pathways in liver regeneration
67. Liver regeneration and hepatocarcinogenesis in transforming growth factor-α-targeted mice
68. Inactivation of the myogenic bHLH gene MRF4 results in up-regulation of myogenin and rib anomalies
69. Expression of TGFα autocrine activity in human colon carcinoma CBS cells is autoregulated and independent of exogeneous epidermal growth factor
70. Hepatocyte growth factor stimulates cell growth and enhances the expression of transforming growth factor a mRNA in AsPC-1 human pancreatic cancer cells
71. Characterization of the effects of human placental HGF on rat hepatocytes
72. Growth stimulation of rat fetal hepatocytes in response to hepatocyte growth factor: Modulation of c-myc and c-fos expression
73. Comparative effects of hepatocyte growth factor and epidermal growth factor on motility, morphology, mitogenesis and signal transduction of primary rat hepatocytes
74. Modifications of the hepatocyte growth factor/c-met pathway by constitutive expression of transforming growth factor-α in rat liver epithelial cells
75. Oncogenes and signal transduction
76. SH2 domains recognize specific phosphopeptide sequence